News about "CDMO"

OneSource and Orbicular Receive US FDA Tentative Approval for Generic Semaglutide

OneSource and Orbicular secure US FDA tentative approval for generic semaglutide injection, advancing ANDA filing for Ozempic with manufacturing support from OneSource.

CDMO | 22/04/2026 | By News Bureau |  126

Morepen Laboratories Bags Zero-Observation USFDA Inspection for Fourth Time

Morepen Laboratories clears its fourth consecutive USFDA inspection at the Masulkhana facility with zero observations (NIL 483), reinforcing its CDMO strength following a INR 825 crore global manufacturing mandate.

CDMO | 21/04/2026 | By News Bureau

Piramal Pharma Solutions Expands ADC Capabilities with Ajinomoto Bio-Pharma Services Pact

Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to accelerate ADC development and manufacturing, enabling access to AJICAP technology.

CDMO | 20/04/2026 | By News Bureau

Symbiosis Pharmaceutical Services Appoints Joanne Anderson as Chief Commercial Officer

Symbiosis Pharmaceutical Services has appointed Joanne Anderson as CCO, tasking her with leading global commercial strategy as the CDMO expands capacity and strengthens presence across North America and Europe.

CDMO | 13/03/2026 | By News Bureau

Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites

Piramal Pharma Solutions has successfully developed and commercialised a tablet-in-capsule drug delivery system in India, enabling flexible dosing, dual-release profiles and improved patient-centric oral therapies.

CDMO | 03/02/2026 | By News Bureau |  173

Agno Pharma Acquires Actylis's CDMO Manufacturing Asset

Agno Pharma has acquired Actylis’s CDMO manufacturing asset, the legacy Cascade Chemistry business based in Eugene, Oregon, strengthening Agno’s U. cGMP API development and manufacturing capabilities.

CDMO | 19/01/2026 | By News Bureau |  169

Rakuten Medical and LOTTE Biologics Sign Manufacturing Deal for Global Oncology Programme

Rakuten Medical has entered into a manufacturing agreement with LOTTE Biologics under which LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates, supporting Rakuten Medical’s global clinical development programmes and future commercialisation in oncology.

CDMO | 19/01/2026 | By News Bureau |  167

Transcenta Therapeutics Signs Strategic Biomanufacturing Collaboration and Licensing Deal with EirGenix

Under the agreement, Transcenta will grant EirGenix a non-exclusive licence to use its Highly Intensified Continuous Bioprocessing (HiCB) platform, including highly productive continuous perfusion and integrated hybrid continuous purification process technologies, along with comprehensive process documentation, know-how, and regulatory support packages.

CDMO | 30/12/2025 | By News Bureau

PharmAla Biotech Australia Ties Up with UK CDMO to Manufacture ALA-002

PharmAla Biotech Australia has contracted a UK-based CDMO to manufacture the drug substance for ALA-002, its patented non-racemic MDMA formulation, ahead of planned phase 2a/2b clinical trials for social anxiety disorder expected to begin in 2026.

CDMO | 16/12/2025 | By News Bureau |  182

Indian Pharmaceutical Alliance Welcomes New Leadership

Dr. Sharvil Patel, Managing Director, Zydus Lifesciences, and Vice President, Indian Pharmaceutical Alliance (IPA), has been appointed President of the alliance, while Glenn Saldanha, Chairman and Managing Director, Glenmark, will serve as the new Vice President.

CDMO | 04/10/2025 | By Dineshwori |  193